Influenza Vaccines Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Influenza Vaccines Market to 2027 - Global Analysis and Forecasts by Vaccine Type (Quadrivalent Vaccines, Trivalent Vaccines); Virus Type (Influenza Virus Type A, Influenza Virus Type B); Age Group (Pediatrics, Adult) and Geography

Report Code: TIPRE00004070 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Influenza is an acute respiratory illness that affects the upper and/or lower respiratory tract. It is caused by influenza virus and can lead to serious complications in people with a variety of chronic illnesses, including asthma, diabetes, heart disease and immunosuppression. Influenza usually of type A or B and this virus is able to change frequently, to avoid human's immune systems. Vaccination is majorly used to protect people from getting the flu.

MARKET DYNAMICS
The influenza vaccines market is anticipated to grow due to the key driving factors such as rising demand for better vaccines, growing research and development activities, increasing governmental initiatives for the vaccine development and increasing geriatric population. The growing aging population and increasing prevalence of chronic diseases across the globe are also expected to fuel the growth of the market during the forecast period.

MARKET SCOPE
The "Global Influenza Vaccines Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of influenza vaccines market with detailed market segmentation by vaccine type, virus type and age group. The global influenza vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading influenza vaccines market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global influenza vaccines market is segmented on the basis of product and application. Based on the vaccine type, the market is classified into quadrivalent vaccines and trivalent vaccines. On the basis of the virus type, the market is segmented into influenza virus type A and influenza virus type B. Based on the age group, the influenza vaccines market is categorized into pediatrics and adult.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global influenza vaccines market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The influenza vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Influenza Vaccines market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the influenza vaccines market in these regions.

MARKET PLAYERS
The reports cover key developments in the Influenza Vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Influenza Vaccines market are anticipated to lucrative growth opportunities in the future with the rising demand for influenza vaccines market in the global market. Below mentioned is the list of few companies engaged in the Influenza Vaccines market.

The report also includes the profiles of key influenza vaccines market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • F. Hoffmann-La Roche Ltd
  • Abbott
  • Seqirus
  • Sanofi
  • GlaxoSmithKline plc.
  • Hualan Biological Engineering Inc
  • Mitsubishi Tanabe Pharma Corporation.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • AstraZeneca
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Influenza Vaccines Market - By Vaccine Type
1.3.2 Influenza Vaccines Market - By Virus Type
1.3.3 Influenza Vaccines Market - By Age Group
1.3.4 Influenza Vaccines Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. INFLUENZA VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INFLUENZA VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INFLUENZA VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. INFLUENZA VACCINES - GLOBAL MARKET OVERVIEW
6.2. INFLUENZA VACCINES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. INFLUENZA VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - VACCINE TYPE
7.1. OVERVIEW
7.2. VACCINE TYPE MARKET FORECASTS AND ANALYSIS
7.3. QUADRIVALENT VACCINES
7.3.1. Overview
7.3.2. Quadrivalent Vaccines Market Forecast and Analysis
7.4. TRIVALENT VACCINES
7.4.1. Overview
7.4.2. Trivalent Vaccines Market Forecast and Analysis
8. INFLUENZA VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - VIRUS TYPE
8.1. OVERVIEW
8.2. VIRUS TYPE MARKET FORECASTS AND ANALYSIS
8.3. INFLUENZA VIRUS TYPE A
8.3.1. Overview
8.3.2. Influenza Virus Type A Market Forecast and Analysis
8.4. INFLUENZA VIRUS TYPE B
8.4.1. Overview
8.4.2. Influenza Virus Type B Market Forecast and Analysis
9. INFLUENZA VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - AGE GROUP
9.1. OVERVIEW
9.2. AGE GROUP MARKET FORECASTS AND ANALYSIS
9.3. PEDIATRICS
9.3.1. Overview
9.3.2. Pediatrics Market Forecast and Analysis
9.4. ADULT
9.4.1. Overview
9.4.2. Adult Market Forecast and Analysis
10. INFLUENZA VACCINES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Influenza Vaccines Market Overview
10.1.2 North America Influenza Vaccines Market Forecasts and Analysis
10.1.3 North America Influenza Vaccines Market Forecasts and Analysis - By Vaccine Type
10.1.4 North America Influenza Vaccines Market Forecasts and Analysis - By Virus Type
10.1.5 North America Influenza Vaccines Market Forecasts and Analysis - By Age Group
10.1.6 North America Influenza Vaccines Market Forecasts and Analysis - By Countries
10.1.6.1 United States Influenza Vaccines Market
10.1.6.1.1 United States Influenza Vaccines Market by Vaccine Type
10.1.6.1.2 United States Influenza Vaccines Market by Virus Type
10.1.6.1.3 United States Influenza Vaccines Market by Age Group
10.1.6.2 Canada Influenza Vaccines Market
10.1.6.2.1 Canada Influenza Vaccines Market by Vaccine Type
10.1.6.2.2 Canada Influenza Vaccines Market by Virus Type
10.1.6.2.3 Canada Influenza Vaccines Market by Age Group
10.1.6.3 Mexico Influenza Vaccines Market
10.1.6.3.1 Mexico Influenza Vaccines Market by Vaccine Type
10.1.6.3.2 Mexico Influenza Vaccines Market by Virus Type
10.1.6.3.3 Mexico Influenza Vaccines Market by Age Group
10.2. EUROPE
10.2.1 Europe Influenza Vaccines Market Overview
10.2.2 Europe Influenza Vaccines Market Forecasts and Analysis
10.2.3 Europe Influenza Vaccines Market Forecasts and Analysis - By Vaccine Type
10.2.4 Europe Influenza Vaccines Market Forecasts and Analysis - By Virus Type
10.2.5 Europe Influenza Vaccines Market Forecasts and Analysis - By Age Group
10.2.6 Europe Influenza Vaccines Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Influenza Vaccines Market
10.2.6.1.1 Germany Influenza Vaccines Market by Vaccine Type
10.2.6.1.2 Germany Influenza Vaccines Market by Virus Type
10.2.6.1.3 Germany Influenza Vaccines Market by Age Group
10.2.6.2 France Influenza Vaccines Market
10.2.6.2.1 France Influenza Vaccines Market by Vaccine Type
10.2.6.2.2 France Influenza Vaccines Market by Virus Type
10.2.6.2.3 France Influenza Vaccines Market by Age Group
10.2.6.3 Italy Influenza Vaccines Market
10.2.6.3.1 Italy Influenza Vaccines Market by Vaccine Type
10.2.6.3.2 Italy Influenza Vaccines Market by Virus Type
10.2.6.3.3 Italy Influenza Vaccines Market by Age Group
10.2.6.4 Spain Influenza Vaccines Market
10.2.6.4.1 Spain Influenza Vaccines Market by Vaccine Type
10.2.6.4.2 Spain Influenza Vaccines Market by Virus Type
10.2.6.4.3 Spain Influenza Vaccines Market by Age Group
10.2.6.5 United Kingdom Influenza Vaccines Market
10.2.6.5.1 United Kingdom Influenza Vaccines Market by Vaccine Type
10.2.6.5.2 United Kingdom Influenza Vaccines Market by Virus Type
10.2.6.5.3 United Kingdom Influenza Vaccines Market by Age Group
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Influenza Vaccines Market Overview
10.3.2 Asia-Pacific Influenza Vaccines Market Forecasts and Analysis
10.3.3 Asia-Pacific Influenza Vaccines Market Forecasts and Analysis - By Vaccine Type
10.3.4 Asia-Pacific Influenza Vaccines Market Forecasts and Analysis - By Virus Type
10.3.5 Asia-Pacific Influenza Vaccines Market Forecasts and Analysis - By Age Group
10.3.6 Asia-Pacific Influenza Vaccines Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Influenza Vaccines Market
10.3.6.1.1 Australia Influenza Vaccines Market by Vaccine Type
10.3.6.1.2 Australia Influenza Vaccines Market by Virus Type
10.3.6.1.3 Australia Influenza Vaccines Market by Age Group
10.3.6.2 China Influenza Vaccines Market
10.3.6.2.1 China Influenza Vaccines Market by Vaccine Type
10.3.6.2.2 China Influenza Vaccines Market by Virus Type
10.3.6.2.3 China Influenza Vaccines Market by Age Group
10.3.6.3 India Influenza Vaccines Market
10.3.6.3.1 India Influenza Vaccines Market by Vaccine Type
10.3.6.3.2 India Influenza Vaccines Market by Virus Type
10.3.6.3.3 India Influenza Vaccines Market by Age Group
10.3.6.4 Japan Influenza Vaccines Market
10.3.6.4.1 Japan Influenza Vaccines Market by Vaccine Type
10.3.6.4.2 Japan Influenza Vaccines Market by Virus Type
10.3.6.4.3 Japan Influenza Vaccines Market by Age Group
10.3.6.5 South Korea Influenza Vaccines Market
10.3.6.5.1 South Korea Influenza Vaccines Market by Vaccine Type
10.3.6.5.2 South Korea Influenza Vaccines Market by Virus Type
10.3.6.5.3 South Korea Influenza Vaccines Market by Age Group
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Influenza Vaccines Market Overview
10.4.2 Middle East and Africa Influenza Vaccines Market Forecasts and Analysis
10.4.3 Middle East and Africa Influenza Vaccines Market Forecasts and Analysis - By Vaccine Type
10.4.4 Middle East and Africa Influenza Vaccines Market Forecasts and Analysis - By Virus Type
10.4.5 Middle East and Africa Influenza Vaccines Market Forecasts and Analysis - By Age Group
10.4.6 Middle East and Africa Influenza Vaccines Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Influenza Vaccines Market
10.4.6.1.1 South Africa Influenza Vaccines Market by Vaccine Type
10.4.6.1.2 South Africa Influenza Vaccines Market by Virus Type
10.4.6.1.3 South Africa Influenza Vaccines Market by Age Group
10.4.6.2 Saudi Arabia Influenza Vaccines Market
10.4.6.2.1 Saudi Arabia Influenza Vaccines Market by Vaccine Type
10.4.6.2.2 Saudi Arabia Influenza Vaccines Market by Virus Type
10.4.6.2.3 Saudi Arabia Influenza Vaccines Market by Age Group
10.4.6.3 U.A.E Influenza Vaccines Market
10.4.6.3.1 U.A.E Influenza Vaccines Market by Vaccine Type
10.4.6.3.2 U.A.E Influenza Vaccines Market by Virus Type
10.4.6.3.3 U.A.E Influenza Vaccines Market by Age Group
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Influenza Vaccines Market Overview
10.5.2 South and Central America Influenza Vaccines Market Forecasts and Analysis
10.5.3 South and Central America Influenza Vaccines Market Forecasts and Analysis - By Vaccine Type
10.5.4 South and Central America Influenza Vaccines Market Forecasts and Analysis - By Virus Type
10.5.5 South and Central America Influenza Vaccines Market Forecasts and Analysis - By Age Group
10.5.6 South and Central America Influenza Vaccines Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Influenza Vaccines Market
10.5.6.1.1 Brazil Influenza Vaccines Market by Vaccine Type
10.5.6.1.2 Brazil Influenza Vaccines Market by Virus Type
10.5.6.1.3 Brazil Influenza Vaccines Market by Age Group
10.5.6.2 Argentina Influenza Vaccines Market
10.5.6.2.1 Argentina Influenza Vaccines Market by Vaccine Type
10.5.6.2.2 Argentina Influenza Vaccines Market by Virus Type
10.5.6.2.3 Argentina Influenza Vaccines Market by Age Group
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. INFLUENZA VACCINES MARKET, KEY COMPANY PROFILES
12.1. F. HOFFMANN-LA ROCHE LTD
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ABBOTT
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SEQIRUS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. SANOFI
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GLAXOSMITHKLINE PLC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. HUALAN BIOLOGICAL ENGINEERING INC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MITSUBISHI TANABE PHARMA CORPORATION.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PFIZER INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MERCK AND CO., INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ASTRAZENECA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. F. Hoffmann-La Roche Ltd
2. Abbott
3. Seqirus
4. Sanofi
5. GlaxoSmithKline plc.
6. Hualan Biological Engineering Inc
7. Mitsubishi Tanabe Pharma Corporation.
8. Pfizer Inc.
9. Merck & Co., Inc.
10. AstraZeneca
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book